MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MPLT MapLight Therapeutics, Inc.

休市中 12-12 16:00:00 EST

20.70

+0.61

+3.01%

盘后20.70

+0.000.00%

16:20 EST

最高21.38	最低20.04	成交量18.07万
今开20.24	昨收20.10	日振幅6.67%
总市值9.39亿	流通市值3.15亿	总股本4,537万
成交额375.53万	换手率1.19%	流通股本1,523万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":20.7,"timestamp":1765573200000,"preClose":20.095,"halted":0,"volume":180681,"hourTrading":{"tag":"盘后","latestPrice":20.7,"preClose":20.7,"latestTime":"16:20 EST","volume":1085,"amount":22452.5,"timestamp":1765574409768},"delay":0,"floatShares":15226707,"shares":45373000,"eps":-133.72789,"marketStatus":"休市中","change":0.605,"latestTime":"12-12 16:00:00 EST","open":20.24,"high":21.38,"low":20.04,"amount":3755302.270917,"amplitude":0.066683,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-133.72789,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":20.095,"postHourTrading":{"tag":"盘后","latestPrice":20.7,"preClose":20.7,"latestTime":"16:20 EST","volume":1085,"amount":22452.5,"timestamp":1765574409768},"volumeRatio":0.5961503186399499},"requestUrl":"/m/hq/s/MPLT","defaultTab":"news","newsList":[{"id":"1192124876","title":"MapLight Therapeutics, Inc.：Leerink Partners启动覆盖，评级为“跑赢大盘”；目标价30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192124876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192124876?lang=zh_cn&edition=full","pubTime":"2025-11-21 20:17","pubTimestamp":1763727449,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.：Leerink Partners启动覆盖，评级为“跑赢大盘”；目标价30美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"gpt_icon":0},{"id":"2583580662","title":"Maplight Therapeutics, Inc.盘中异动 早盘大幅拉升6.70%报16.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583580662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583580662?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:34","pubTimestamp":1762958081,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时34分，Maplight Therapeutics, Inc.股票出现异动，股价大幅拉升6.70%。截至发稿，该股报16.08美元/股，成交量3256股，换手率0.01%，振幅0.00%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为4586.14%、304.64%、64.17%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.，振幅分别为46.48%、33.67%、14.86%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MPLT","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2578625444","title":"美股异动 | 生物医药企业Maplight Therapeutics(MPLT.US)登陆美股市场 股价涨超15.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578625444","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578625444?lang=zh_cn&edition=full","pubTime":"2025-10-27 23:58","pubTimestamp":1761580713,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，生物医药企业Maplight Therapeutics(MPLT.US)登陆美股市场，截至发稿，该股涨超15.8%，报19.7美元。IPO价格为17美元。MapLight由国际知名的精神病学和神经科学研究领袖创立，旨在解决患者缺乏针对特定神经回路的药物疗法的问题。MapLight称，其平台能够识别与疾病有因果关系的神经回路，并针对这些回路进行治疗调控。该公司已开发出一系列候选产品，用于治疗一些最具挑战性的中枢神经系统疾病，例如精神分裂症、阿尔茨海默病和自闭症谱系障碍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","BK4539","161726","BK4139","MPLT","LENZ","BK4007"],"gpt_icon":0},{"id":"1142199633","title":"异动解读 | MapLight Therapeutics首日挂牌纳斯达克，股价盘中大涨19.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142199633","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142199633?lang=zh_cn&edition=full","pubTime":"2025-10-27 23:50","pubTimestamp":1761580221,"startTime":"0","endTime":"0","summary":"生物制药公司MapLight Therapeutics今日在纳斯达克挂牌上市，股价表现强劲，盘中大涨19.53%。据悉，MapLight Therapeutics的股票在首个交易日开盘价较发行价高出11.8%。作为一家专注于药物开发的生物科技公司，MapLight Therapeutics的成功上市不仅为公司带来了可观的融资，也为其未来的研发和业务扩张奠定了坚实的基础。分析人士指出，MapLight Therapeutics的股价强势上涨反映了市场对生物医药行业的持续看好，特别是在当前全球健康意识不断提升的背景下。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MPLT"],"gpt_icon":0},{"id":"2573969662","title":"MapLight Therapeutics(MPLT.US)拟募资2.51亿美元 美政府停摆下启用罕见法律条款推进上市流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2573969662","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573969662?lang=zh_cn&edition=full","pubTime":"2025-10-07 23:19","pubTimestamp":1759850363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，总部位于美国加州红木城的生物技术公司MapLight Therapeutics周一公布首次公开募股条款，计划通过发行1480万股普通股，以每股17美元的价格募集约2.51亿美元。为绕过这一障碍，MapLight决定依据《1933年证券法》第8条的罕见条款推进上市流程。MapLight表示，计划在20天后正式定价，但若SEC在10月26日前恢复正常运作，公司将重新评估是否继续依赖该条款。MapLight成立于2018年，计划在纳斯达克挂牌上市，股票代码为“MPLT”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4539","MPLT","BK4007","BK4139"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":0.1195},{"period":"1month","weight":0.4315},{"period":"3month","weight":0.2176},{"period":"ytd","weight":0.2176}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MapLight Therapeutics, Inc.于2018年11月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，专注于改善患有衰弱性中枢神经系统 (CNS) 疾病的患者的生活。公司旨在解决患者缺乏针对特定神经回路的药物疗法的问题。其发现平台旨在识别与疾病有因果关系的神经回路，并针对这些神经回路进行治疗调控。其主要候选产品ML-007C-MA是一种固定剂量复方制剂，旨在治疗精神分裂症和阿尔茨海默病引起的精神病，旨在激活中枢神经系统中特定的毒蕈碱受体，同时最大限度地减少外周副作用。","exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MapLight Therapeutics, Inc.(MPLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MapLight Therapeutics, Inc.,MPLT,MapLight Therapeutics, Inc.股票,MapLight Therapeutics, Inc.股票老虎,MapLight Therapeutics, Inc.股票老虎国际,MapLight Therapeutics, Inc.行情,MapLight Therapeutics, Inc.股票行情,MapLight Therapeutics, Inc.股价,MapLight Therapeutics, Inc.股市,MapLight Therapeutics, Inc.股票价格,MapLight Therapeutics, Inc.股票交易,MapLight Therapeutics, Inc.股票购买,MapLight Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MapLight Therapeutics, Inc.(MPLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}